(2023)
Serum metabolome signatures characterizing co-infection of Plasmodium falciparum and HBV in pregnant women.
Diseases 11(3),
94.

Prof. Dr. Sebastian Weis
Translational Infection Medicine · Head +49 3641 532-1771 Sebastian.Weis@med.uni-jena.deCurriculum vitae
Main Research Areas
- Disease Tolerance to Infection
- Innate Immunity
- Heme Metabolism
- Metabolic Adaptation
- Sepsis
- Staphylococcus aureus Bacteremia
Professional Career
since 2021 | W3 Professor for "Translational Infection Research", FSU Jena |
since 2021 | Member of the Ethics Committee, FSU Jena |
2021 | Call W2 Professorship "Inflammation and Haematopoiesis", TU Dresden, declined |
2019 | Senior Physician, Institute for Infectious Medicine and Hospital Hygiene |
2019 | Call W3 Professorship "Clinical Infectious Disease", Tübingen, declined |
2019 | Call W2 professorship "Clinical Infectiology and Immunology", UKE Hamburg, declined |
seit 2019 | Subgroup Coordinator, Cluster of Excellence "Balance of the Microverse", FSU Jena |
2018 | Subspecialisation in Clinical Infectious Disease |
2018 | Member of the Board IFB Center for Sepsis Control and Care, FSU Jena |
2018 | Member Cluster of Excellence "Balance of the Microverse”, FSU Jena |
2018 | Examiner 3rd State Examination in Human Medicine |
2017 | Habilitation and Venia legendi Internal Medicine, FSU Jena |
2015 | Training in Clinical Infectiology with Prof. M.W. Pletz, JUH |
2012-2015 | Postdoctoral Fellow, Instituto Gulbenkian de Ciência (IGC), Portugal |
2012 | Specialist Examination in Internal Medicine |
2007-2012 | Specialist Training in Internal Medicine with Prof. J.Mössner, Leipzig University Hospital and Prof. G.Hindricks, Heart Center Leipzig |
2008 | Medical Dissertation “On Paraenzymatic Functions of Heme Oxygenease-1” (summa cum laude), University of Leipzig, Germany |
2007 | Visiting Researcher, MRC Fajara, The Gambia, West-Afrika |
2006 | Approbation/Physician's license |
2005 | Clinical Elective, Medical Research Council, Fajara, The Gambia |
2002-2003 | Visiting Researcher, Dept. of Pediatrics, Stanford University, USA |
1999-2006 | Studies of Medicine, University of Leipzig, Germany; Practical Year: Children´s Hospital of Philadelphia, USA and St. Georg Hospital, Leipzig, Germany |
Awards · Appointments · Scientific Activities
2018 | Winner Science Slam, KIT 2018 |
2018 | Best Oral Presentation Award, 10th Meeting of HO, Seoul |
2017 | Hugo-Schottmüller Award of the German Sepsis Society |
2017 | Best Abstract Award, International Sepsis Forum |
2012-2014 | DFG Fellowship for Research Abroad |
2010 | Formula 1 Research Fellowship, University of Leipzig |
2008 | Doberentz Prize of the University of Leipzig for Outstanding Dissertations |
Publications
(2023)
Non-patient-related SARS-CoV-2 exposure from colleagues and household members poses the highest infection risk for hospital employees in a German university hospital: follow-up of the prospective Co-HCW seroprevalence study.
Infection 51(4),
1051-1059.
(2023)
Targeting the host response in sepsis: current approaches and future evidence.
Crit Care 27(1),
478.
(2023)
Simvastatin in critically Ill patients with Covid-19.
N Engl J Med 389(25),
2341-2354.
(2023)
Public health risk communication through the lens of a quarantined community: Insights from a coronavirus hotspot in Germany.
PLoS One 18(10),
e0292248.
(2023)
What's new in intensive care: disease tolerance.
Intensive Care Med 49(10),
1235-1237.
(2023)
Persistent humoral and CD4+ TH cell immunity after mild SARS-COV-2 infection-the CoNAN long-term study.
Front Immunol 13,
1095129.
(2022)
Persistent T-cell reactivity in a seronegative patient after SARS-CoV-2 infection and one vaccination.
Vaccines (Basel) 10(1),
114.
(2022)
Development of a new antigen-based microarray platform for screening and detection of human IgG antibodies against SARS-CoV-2.
Sci Rep 12(1),
8067.
(2022)
Complicated and uncomplicated S. aureus bacteraemia: an international Delphi survey among infectious diseases experts on definitions and treatment.
Clin Microbiol Infect 28(7),
1026.e7.